Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-01 · accession 0001213900-23-010882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-13 | 2023-02-01 | BJDX | Dey Indranil | Pres, CEO, Dir | A - Grant | $0.44 | +159.1K | 606.1K | +36% | +$70.0K | |
| 2023-02-13 | 2023-02-01 | BJDX | Dey Indranil | Pres, CEO, Dir | F - Tax | $0.44 | -55.6K | 550.5K | -9% | -$24.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | A | A | 159,090 | $0.44 | 606,150 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | F | D | 55,612 | $0.44 | 550,538 | D | — | — |